Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.
Shen S, Ma W, Brown D, Da Cruz Paula A, Zhou Q, Iaosonos A, Tessier-Cloutier B, Ross DS, Troso-Sandoval T, Reis-Filho JS, Abu-Rustum N, Zhang Y, Ellenson LH, Weigelt B, Makker V, Chui MH. Shen S, et al. Mod Pathol. 2023 Nov;36(11):100299. doi: 10.1016/j.modpat.2023.100299. Epub 2023 Aug 7. Mod Pathol. 2023. PMID: 37558129 Free PMC article.
Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma.
Stolnicu S, Praiss AM, Allison D, Tessier-Cloutier B, Flynn J, Iasonos A, Hoang L, Terinte C, Pesci A, Mateoiu C, Lastra RR, Kiyokawa T, Ali-Fehmi R, Kheil M, Oliva E, Devins K, Abu-Rustum N, Soslow RA. Stolnicu S, et al. Int J Gynecol Pathol. 2024 May 1;43(3):203-214. doi: 10.1097/PGP.0000000000000979. Epub 2023 Nov 9. Int J Gynecol Pathol. 2024. PMID: 38085957
Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
Wang L, Vasudevaraja V, Tran I, Sukhadia P, Reuter VE, Abu-Rustum NR, Rubinstein MM, Gopalan A, Ross D, Snuderl M, Chiang S. Wang L, et al. Int J Gynecol Pathol. 2025 Jan 1;44(1):88-93. doi: 10.1097/PGP.0000000000001029. Epub 2024 May 29. Int J Gynecol Pathol. 2025. PMID: 38833720
Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations.
Gordhandas S, Gellman C, Ingber S, Yen T, Kahn R, Kyana S, Taffuri A, Sokolowski S, Martinez D, Garcia P, Mullangi S, Long Roche K, Abu-Rustum N, Mangino D, Pilewskie M, Sutton E, Aviki E. Gordhandas S, et al. Among authors: abu rustum n. Gynecol Oncol. 2025 Jan 3;193:20-23. doi: 10.1016/j.ygyno.2024.12.016. Online ahead of print. Gynecol Oncol. 2025. PMID: 39754916
Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?
Liu YL, Sia TY, Varice N, Wu M, Byrne M, Khurram A, Kemel Y, Sheehan M, Galle J, Sabbatini P, Brown C, Roche KL, Chi D, Solit DB, Mueller J, Stadler ZK, Hamilton JG, Aghajanian C, Abu-Rustum NR. Liu YL, et al. Among authors: abu rustum nr. JCO Precis Oncol. 2024 Dec;8:e2400525. doi: 10.1200/PO-24-00525. Epub 2024 Dec 23. JCO Precis Oncol. 2024. PMID: 39715484
511 results